Canada probes Sepracor worker's death

Labor officials in Nova Scotia want to know to why a 46-year-old quality-control technician died 18 hours after inhaling D-Malic acid at a Sepracor plant. A stop-work order has been issued to the laboratory "until further notice." Report

Suggested Articles

Horizon Therapeutics has notched an FDA approval for its rare eye disease med Tepezza (teprotumumab), a possible blockbuster drug in the making.

Eli Lilly has a pipeline stuffed with a host of assets and has decided it needs a new injectable drug and device plant to manufacture some of them.

After Clovis’ Rubraca snagged an FDA boost in prostate cancer last week, AZ and Merck’s rival Lynparza has matched it with a boost of its own.